Contribution: Industrial Research Assistance Program – Contributions to Firms
QurCan Therapeutics Inc.
$183,500.00
RNA therapeutic using nanoparticle-based platform
FY 2022-23 · 2022-09-01
Summary
QurCan Therapeutics is developing the next generation RNA therapeutics using its proprietary BBB-crossing nanoparticle platform technology to overcome the treatment-resistance in brain tumors.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Toronto|Toronto, Ontario, Canada
Recipient Type
For-profit organization
Business Number
751921719
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2023-09-30
Agreement Number
995465
Agreement Start Date
2022-09-01
Agreement Title
RNA therapeutic using nanoparticle-based platform
Agreement Title (French)
Thérapeutique à base d'ARN utilisant une plateforme à nanoparticules
Agreement Type
Contribution
Agreement Value
$183,500.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
QurCan Therapeutics is developing the next generation RNA therapeutics using its proprietary BBB-crossing nanoparticle platform technology to overcome the treatment-resistance in brain tumors.
Description (French)
QurCan Therapeutics développe la prochaine génération de thérapies à base d'ARN en utilisant sa plateforme technologique exclusive de nanoparticules traversant la barrière hémato-encéphalique pour surmonter la résistance au traitement des tumeurs cérébrales.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
University--Rosedale
Federal Riding (French)
University--Rosedale
Federal Riding Number
35110
NAICS Code
3254
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
751921719
Recipient City
Toronto|Toronto
Recipient Country
CA
Recipient Legal Name
QurCan Therapeutics Inc.
Recipient Postal Code
M5G 1M1
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2022-2023-Q2-995465
